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Abstract
Background: There has not been sufficient evidence to support the Asians being less susceptible to pulmonary embolism
(PE) than other ethnicities, because the prevalence of PE/deep venous thrombosis (DVT) in different racial and ethnic groups
has not been carefully studied until recently except in Caucasians. To test the hypothesis that the Chinese population has a
lower risk for PE, this study comprehensively assessed the hospital-based incidence and case fatality rates for PE during the
1997–2008 in China.
Methods: A registration study of patients with suspected PE syndromes admitted to 60 level-3 hospitals involved in the
National Cooperative Project for the Prevention and Treatment of Venous Thromboembolism (NCPPT) was conducted from
January 1997 to December 2008. The only exclusion criterion was an age of less than 18 years. Helical computed
tomography scan, ventilation-perfusion lung scintigraphy or pulmonary angiography was carried out before or after
hospitalization. All images were reviewed and evaluated independently by two specialists.
Results: A total of 18,206 patients were confirmed with PE from 16,972,182 hospital admissions. The annual incidence was
0.1% (95% CI: 0.1% to 0.2%). The overall incidence of PE in male patients (0.2%, 95% CI: 0.1% to 0.3%) was higher than that
in female patients (0.1% and 95% CI: 0.0% to 0.1%). An increasing incidence gradient for PE was noticed from Southern to
Northern China. In addition, the case fatality rate was apparently decreasing: 25.1% (95% CI: 16.2% to 36.9%) in 1997 to 8.7%
(95% CI: 3.5% to 15.8%) in 2008.
Conclusions: Our findings suggest the relatively stable PE incidence and decreasing fatality trends in Chinese hospitals may
be partially attributable to the implementation of the NCCPT and suggest the government should reevaluate the severity of
PE so that health resources for the prevention, diagnosis and treatment of PE could be used to their fullest.
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Introduction
In the United States, the incidence of pulmonary embolisms
(PE) among hospitalized patients from 1979 to 1999 was a stable
0.4% of admissions [1]. PE comprised more than 30.0% of all
venous thromboembolism (VTE) [2,3], the third most common
cardiovascular disease in the United States after acute ischemic
cardiovascular syndromes and stroke [4]. During the past several
decades, considerable progress has been made in the prevention
and treatment of PE, resulting in a substantial decline in PE-
specific mortality from 45 to 33 deaths per million persons [5].
In Asia, studies showed that the directly standardized incidence
(number of cases within a population comprised of a single racial
group) of all VTE events was strikingly lower among Asians/
Pacific Islanders (29/100,000/yr) than among Caucasians (103/
100,000/yr) [6,7]. Compared to Caucasians, the incidence of
VTE in Asians/Pacific Islanders was approximately 3-fold lower
for secondary VTE events and 5-fold lower for idiopathic VTE
events, and a similar incidence of VTE among Asians has been
reported in Hong Kong [8,9] and Japan [10].
Since the presence of factor V Leiden or the prothrombin gene
mutation (G20210A) is known to be associated with a 3 to 4-fold
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*higher risk for developing VTE [11,12], it is logical to assume that
the prevalence of VTE would be lower in Asian populations than
in Caucasian populations, because the prevalence of these two
genetic traits is much lower in Asian populations than Caucasian
populations [13]. However, some studies have suggested that the
incidence of asymptomatic VTE may not differ substantially
between Asians/Pacific Islanders and Caucasians [14,15]. In fact,
the conjecture that Asians’ susceptibility to PE is less than other
ethnic groups has not been sufficiently supported because of a lack
of careful studies into the prevalence of VTE/PE among ethnic
groups other than Caucasians.
In China, the National Cooperative Project for the Prevention
and Treatment of Venous Thromboembolism (NCPPT) [16] was
initiated in 2001 to improve the awareness among clinicians and to
standardize the management practice for the diagnosis and
treatment of VTE. A total of 60 level-3 hospitals (major tertiary
referral centers in provincial and major urban hospitals) were
recruited, covering 22 provinces and 2 autonomous cities (Beijing
and Shanghai). A multicenter registry of patients admitted to
hospitals with suspected VTE syndromes was initiated among the
60 hospitals, allowing the NCPPT to gather valuable information
about the epidemiology of PE. In this first comprehensive
assessment of the incidence and case fatality rate of PE in Chinese
hospitals from 1997 to 2008, the hypothesis that the Chinese
population has a lower risk for PE was confirmed
17. This
information will help to maximize the application of both public
health and clinical resources to the prevention, diagnosis and
treatment of PE.
Methods
Registry Design and Data collection
The NCPPT project in China involved a multicenter registry of
patients admitted to hospitals with suspected VTE syndromes as
well as a multicenter randomized and controlled trial to evalu-
ate the efficacy and safety of PE anticoagulation and prophylaxis
among Chinese patients. The institutional review boards at Beijing
Chao-Yang Hospital, Capital Medical University approved the
protocol.Written,informed consentwasobtained forallprospective
data collected for the purposes of this study prior to the onset of the
study. Consent was not necessary for retrospective data used in this
study because the data were analyzed anonymously.
Between January of 1997 and December of 2008, consecutive
patients admitted to the inpatient ward with a diagnosis of
suspected PE were registered from 60 hospitals (see the Appendix),
covering 22 provinces and 2 autonomous cities (Beijing and
Shanghai). The only exclusion criterion was an age of less than 18
years.
All participating hospitals were major provincial-level tertiary
referral centers or major urban hospitals with facilities for
conducting helical computed tomography scan, ventilation-
perfusion lung scintigraphy, pulmonary angiography and echo-
cardiogram visualization of thrombus. A registry coordinator
controlled the quality of data collection (e.g. internal validity and
coherence) at each participating center and recorded the data
from each patient on a case report form. Specialist staff employees
skilled in cardiovascular and pulmonary diseases, helical computed
tomography scanning, pulmonary angiography and ultrasound
were involved in the diagnosis and treatment of the PE patients
after standardized training according to our standard protocol.
Table 1. The incidence of PE in hospitalized patients by age
and gender in China (%) during 12 years (from 1997 to 2008).
Age Total Men Female
,=30 0.07(0.02–0.13) 0.12(0.06–0.21) 0.05(0.02–0.11)
31–40 0.06(0.02–0.12) 0.14(0.08–0.23) 0.03(0.01–0.09)
41–50 0.13(0.07–0.22) 0.16(0.09–0.25) 0.10(0.05–0.18)
51–60 0.12(0.06–0.21) 0.14(0.08–0.23) 0.10(0.05–0.18)
61–70 0.14(0.08–0.23) 0.19(0.11–0.29) 0.12(0.06–0.21)
71+ 0.10(0.05–0.18) 0.44(0.32–0.59) 0.05(0.02–0.11)
Total 0.11(0.05–0.19) 0.18(0.10–0.28) 0.07(0.02–0.13)
doi:10.1371/journal.pone.0026861.t001
Figure 1. Incidence and case fatality rates for PE in hospitalized adults from 1997 to 2008.
doi:10.1371/journal.pone.0026861.g001
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with conformed PE were included in the registry.
The data from January of 1997 to December of 2000 was
collected retrospectively by a review of the medical records. For
this study, the following data were collected prospectively from
2001: demographic data, types and results of diagnosis methods
and prognosis. Raw data were checked then forwarded to the
Study Coordinating Centre in Beijing Chao-yang Hospital where
data were input into a duplicate computerized database and then
checked again.
Study Outcome
All patients were identified with a discharge diagnosis of PE
(first-episode or recurrent PE) based on the St. Anthony’s
International Classification of Disease, Ninth Revision (ICD-9)
diagnostic codes, including 415.1 (pulmonary embolism and
infarction), 415.11 (iatrogenic pulmonary embolism and infarc-
tion), 415.19 (pulmonary embolism other), 634.6, 635.6, 636.6,
637.6, and 638.6 (pulmonary embolism with abortion), 639.6
(pulmonary embolism with ectopic pregnancy), and 673.2
(pulmonary embolism with pregnancy, childbirth or the puerpe-
rium).
Helical computed tomography scan, ventilation-perfusion
lung scintigraphy or pulmonary angiography was carried out
before or after hospitalization. All images were reviewed and
evaluated independently by two specialists using methods from
previous studies [17,18,19]. Death was considered to be
attributable to PE if the diagnosis was documented at autopsy
or if the patient died shortly after an objective confirmation of
symptomatic PE along with an absence of an alternative
diagnosis. An independent outcome committee composed of
four specialists in pulmonary circulation (Wang Chen, Yang
Yuanhua, Chen Xiansheng and Lu Weixuan) reviewed and
adjudicated all study outcomes.
Analysis
Data management and statistical analysis were conducted by
SAS software version 9.1.3 (SAS Institute Inc, Cary, NC, USA,
2006). Incidences (number of diagnoses/100 hospitalizations) of
PE in hospitalized adults (aged 18 years and above) were
calculated as the number of patients with the diagnosis divided
by the number of hospital discharges from 1997 to 2008 multiplied
by 100 annually. The annual case fatality rate for PE was
calculated as the number of deaths from PE per 100 hospitalized
PE patients. Both the incidence and the case fatality rate were
stratified into 10-year age groups, gender and geographical region
(Northern China and Southern China according to the Huai
River-Qinling Mountain line). Within these strata, the rates were
estimated with 95% confidence intervals (CI) using the accurate
calculation of CI for Poisson distribution. A chi-square test was
used to compare the various frequencies with a,0.05. Poisson
regression analysis was used to evaluate the relative risk (RR) for
the incidence and fatality of PE when the age, gender and regional
differences were compared.
Figure 2. The regional distribution of incidence for PE in China.
doi:10.1371/journal.pone.0026861.g002
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Among the 60 hospitals, 21 hospitals were located in the largest
cities in China, including Beijing and Shanghai. The remaining
hospitals were located in provincial capitals or other major cities.
The participating hospitals were widely distributed across the
country, covering Northeastern China (5 hospitals), Northern
China (21 hospitals), Central-Southern China (14 hospitals),
Eastern China (12 hospitals), Southwestern China (4 hospitals)
and Northwestern China (4 hospitals). From January of 1997
to December of 2008, hospitalization data were collected from
18,206 PE diagnosed patients from a total of 16,972,182
discharged patients throughout the participating hospitals. A total
of 13,137 PE patients from 8,289,509 hospital admissions in 36
hospitals located in Northern China and 5,069 patients from
8,682,673 hospital admissions in 24 hospitals located in Southern
China were detected. Among these 18,206 patients with PE,
patients aged 50 and above were more frequent (70.3%). In
addition, male patients (10,425) accounted for 57.3% of all
patients.
The age-specific incidence of PE increased with age, especially
for aged male patients (Table 1). The incidence of PE among
patients 70 years old and above was 0.4% (95% CI: 0.3% to
0.6%). The overall incidence of PE in male patients (0.2% and
95% CI: 0.1% to 0.3%) was higher than that in female patients
(0.1% and 95% CI: 0.0% to 0.1%). However, the discrepancy
between genders was not statistically significant, because the 95%
CI overlapped.
The annual incidence increased sharply from 0.0% (95% CI:
0.0% to 0.1%) in 1997 to 0.1% (95% CI: 0.1% to 0.2%) in 2003,
then remained at 0.1% (95% CI: 0.1% to 0.2%) (Figure 1).
Conversely, the case fatality rate decreased from 25.1% (95% CI:
16.2% to 36. 9%) in 1997 to 8.6% (95% CI: 3.5% to 15.8%) in
2008 (Figure 1).
In addition, the region-specific incidences and case fatalities
were mapped in Figure 2 and Figure 3 respectively. The
incidence of PE increased from Southern to Northern China,
whereas the case fatality rate decreased. A further analysis of the
discrepancy between the North and the South showed that the
incidence of PE in hospitalized patients in Northern China (0.2%)
over the 12 year period were higher than in Southern China
(0.1%) (Figure 4). Poisson regression also provided evidence for a
difference in incidence of PE between Northern and Southern
China, the value of relative risk (RR) being 2.7 (95% CI: 2.6 to
2.8). In contrast, the case fatality rate for PE was lower in the
North (10.9%) than in the South (15.3%) with an RR value of 0.7
(95% CI: 0.6 to 0.8).
Discussion
From this multicenter registration study on the incidence and
case fatality rate of PE, we found that the annual incidence
increased sharply from 0.0% (95% CI: 0.0% to 0.1%) in 1997 to
0.1% (95% CI: 0.1 to 0.2) in 2003, and remained at 0.1% (95%
CI, 0.1% to 0.2%) through 2008, suggesting that the incidence of
PE was lower in Chinese hospitals than in USA hospitals (0.4%)
Figure 3. The regional distribution of case fatality rates for PE in China.
doi:10.1371/journal.pone.0026861.g003
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was shown in the present study and the incidence of PE was higher
in male patients than in female patients.
Our study revealed that 69.2% of PE patients were from 41 to
70 years old and that in this age range the incidence for PE was
about 0.1%; lower than findings reported by Stein [21] (0.2% for
patients aged 40 to 59; 0.3% for patients aged 60 to 69). Previous
studies have shown that the incidence of first-time VTE rises
exponentially with age, increasing dramatically after 60 years of
age [22,23]. The incidence of PE in Chinese men increased
exponentially after 70 years of age (0.4%), dramatically higher
than other age groups (0.1%–0.2%). Conversely, the incidence of
PE in female patients declined sharply from 0.10 (40–69 age
group) to 0.05% after 70 years of age. The effect of gender on the
incidence of PE observed in our study was not consistent with
other studies. Stein and Anderson reported a similar incidence in
both sexes [1,24]. But Silverstein noted a higher age-adjusted
incidence among males than females (0.13% vs 0.11%, respec-
tively) [22]. Kniffin also reported that among patients aged 65
years and above women had a lower risk of PE and the value of
RR was 0.9 (95% CI, 0.8 to 0.9) [25]. The strikingly lower
incidence of PE among elder Chinese women may be because of
the lower hospitalization rates for elder Chinese women (6.5% vs
8.8% in 2003; 12.9% vs 14.8% in 2008) than elder Chinese men
[26], less prevalent use of oral contraceptives and postmenopausal
hormone replacement.
In addition, the present study has shown an increase in the
annual incidence of PE from 1997 to 2004. The potential
explanations are: (1) an increased rate of detection of PE
because of the implementation of NCPPT; (2) the increased
availability and use of diagnostic technologies such as ventila-
tion-perfusion lung scintigraphy and computed tomographic
pulmonary angiography (CTPA). The incidence of PE was
lower in hospital patients in China than in the USA (0.3% to
0.4% in hospitalized patients in large urban hospitals, major
university hospitals and community/teaching general hospitals)
[27–29]. These differences may be partly because of a difference
in risk-level factors for PE and a difference in the accuracy of
diagnoses. The previously reported findings among Hong Kong
Chinese (0.04%, about one-tenth of western communities) [8,9]
suggested the possibility of an underestimation of risk for PE
among the Chinese population. Therefore, our findings
demonstrate that the difference in the incidence of PE between
Chinese and Western populations is smaller than that previously
reported.
However, as the incidence of PE increased, the case fatality rate
for PE declined annually. Stein et al. reported that the incidence of
PE among hospitalized adults aged $20 years did not change
during the 1979 to 1999 period [1]. In addition, he also found that
the diagnosis rate decreased over that period [30]. Lilienfeld et al.
reported that the population mortality for PE declined over the
same period [31]. However, Stein et al. reported that the case
fatalityrateforPE increased from 1979 to 1989,and then decreased
from 1990 to 1998. The authors suggested that the declining
population mortality rate for PE from 1979 to 1989 could be
because of a decreased incidence of PE from improved prophylaxis;
whereas the continuing decline in population mortality rate for PE
through 1998 reflected a decreased case fatality rate from earlier
and better management [3]. The drop in PE case fatality rate found
in this study may be because of economic development, social
progress and improvements in medical treatment and services.
More importantly, however, the implementation of NCPPT [16]
mayhave improvedawarenessaswellasthequalityofdetectionand
management of patients with VTE.
An increase in the incidence of PE from the South to the North
was discovered in our study, concomitant with a slight decline in
Figure 4. The discrepancy between the North and the South in incidence and case fatality rates for PE in China from 1997 to 2008.
doi:10.1371/journal.pone.0026861.g004
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incidence of PE has not been discussed in previous studies, a
South to North difference in coronary heart disease and stroke in
China has been reported [32]. This difference was attributed to
regional differences in cardiovascular risk factors, including
hypertension, dyslipidemia, obesity and diabetes [33–35]. It has
been shown that these factors are also associated with an
increased risk for PE [36]. However, differences in levels of
detection and treatment for PE between the North and the South
may contribute to the reported regional difference in the case
fatality rate for PE.
The present study has several limitations. Our findings were
based entirely on discharge data rather than on the general
population, so the national epidemiological trends for PE could
not be evaluated more precisely. Second, the protocol was not
designed to track multiple admissions for individuals and thus
failed to evaluate the incidence of first episode PE. Third, our
discharge data did not contain the patients that had died outside of
the hospital, at home or in a nursing facility, because it was
assumed that only a small number of those suffering from PE were
likely to seek medical care and thus be admitted to the hospital.
Moreover, our data are exclusively derived from tertiary care
hospitals (major tertiary referral centers in provincial hospitals and
major cities) and do not involve any information from secondary
care hospitals, in which the incidence of PE would be lower and
the fatality would be higher as a result of poor diagnostic and
treatment facilities for PE. Finally, we were unable to explore the
effects from factors other than age, gender and region by
multivariate Poisson regression analysis in this study because of a
limited access to risk factor information for PE (socioeconomic
status, obesity etc.).
Despite these limitations, our findings suggested a rising and
then relatively stable incidence of PE among hospital patients in
China (0.1%) and a declining annual case fatality rate, partly
because of the implementation of NCCPT. In addition, an
increase in the incidence of PE from the South to the North was
shown in this study and the incidence of PE was higher in male
patients than in female patients. The evidence suggests that the
substantial decline in PE-specific mortality and the annual age-
adjusted mortality from PE is a result of improved prevention
and treatment for PE [5]. Therefore, this first comprehensive
assessment on the incidence and case fatality of PE in hospital
patients during the 1997–2008 period in China should encourage
the government to reevaluate the burden of disease from PE so
that both public health and clinical resources for the prevention,
diagnosis and treatment of PE will be used to their fullest.
Moreover, the number one priority in the future prevention and
treatment of PE in China may be to reduce the regional
differences between the North and the South.
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